# PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) · Edgar & Edgarette company card

> Prothena Corporation Public Limited Company (PRTA) saw revenue fall 92.8% in FY2025 to $10 million, operating margin -2216% against a -3.8% median for pharmaceutical preparations, equity 85.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1559053 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PRTA) · [JSON](https://www.pops4.com/boards/company/PRTA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $10M |
| Revenue growth, 1 year | -92.8% |
| Revenue growth per year | -53.1% |
| Operating margin | -2216.4% (prior year -114.4%) |
| Net margin | -2520.6% |
| Operating cash flow | −$164M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $308M |
| Long-term debt | — |
| Total assets | $327M |
| Total equity | $280M |
| Equity ÷ assets | 85.8% |
| Return on equity | -87.0% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -5.98 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · slow and jumpy: growing slower than its size class, with revenue that swings more; operating cash flow was negative; operating loss: a margin of -2216.4% in FY2025; revenue is hard to predict: its 80% range is ±84%
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $9.7M (FY2025). Experience: revenue down 92.8% on the year, down 53.1% a year over 4 years; operating margin -2216.4%, down from -114.4%. Soundness: equity 85.8% of assets, return on equity -87.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $889K and $10.5M next year (method v4.1: its own 4-year record of growth weighed at 50% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $750K to $12.5M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -2216.4% against a -3.8% median; growth -92.8% against 13.7%.

Range logged 2026-10-05, receipt c08892c9ffc86389, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-10-02 ([filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000024/0001559053-26-000024-index.htm))

## Recent filings

- 10-Q · filed 2026-11-05 · [filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000031/0001559053-26-000031-index.htm)
- 8-K · filed 2026-11-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000030/0001559053-26-000030-index.htm)
- 8-K · filed 2026-10-29 · 1.02 Termination of a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000026/0001559053-26-000026-index.htm)
- 8-K · filed 2026-10-02 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000024/0001559053-26-000024-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000022/0001559053-26-000022-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1559053/000155905326000021/0001559053-26-000021-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001559053.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1559053

## Cite

POPS4, Edgar & Edgarette: PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/PRTA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

